MedPath

A study on change in transfusion requirements in premature after the implementation of blood conserving strategies

Not Applicable
Conditions
Health Condition 1: D758- Other specified diseases of bloodand blood-forming organs
Registration Number
CTRI/2020/12/029598
Lead Sponsor
Vishnu Anand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Neonates admitted to NICU inborn OR outborn transferred in within first 24 hours of life

With gestational age less than or equal to 30 weeks who survived till discharge

Whose parents are willing to participate

Exclusion Criteria

Babies with major malformations or requiring major surgery

Babies with hemolytic disease

Informed consent not obtained

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the proportion of neonates less than or equalto 30 weeks of gestation at birth; who receive <br/ ><br>transfusions <br/ ><br>between 2 groups Before and After implementation of Blood Conservation Strategies, <br/ ><br>up to 44 weeks post menstrual ageTimepoint: 44 weeks PMA
Secondary Outcome Measures
NameTimeMethod
To compare between the 2 groups: <br/ ><br>1. Mean transfusion events per neonate <br/ ><br>2. Mean of Cumulative estimated volumes of intensive care associated blood losses during <br/ ><br>hospital stay. <br/ ><br>3. Outcomes- maximum drop in Hemoglobin, proportions of :sepsis, BPD, IVH grade 3 and <br/ ><br>more, ROP requiring laser, NEC Stage 2 and above. <br/ ><br>4. Median duration of hospital stay and arterial line daysTimepoint: 18 month
© Copyright 2025. All Rights Reserved by MedPath